help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 24, 2009, doi:10.1164/rccm.200904-0493OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200904-0493OCv1
181/1/21    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Brindicci, C.
Right arrow Articles by Ito, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brindicci, C.
Right arrow Articles by Ito, K.
American Journal of Respiratory and Critical Care Medicine Vol 181. pp. 21-30, (2010)
© 2010 American Thoracic Society
doi: 10.1164/rccm.200904-0493OC


Original Article

Nitric Oxide Synthase Isoenzyme Expression and Activity in Peripheral Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease

Caterina Brindicci1, Sergei A. Kharitonov1, Misako Ito1, Mark W. Elliott2, James C. Hogg2, Peter J. Barnes1 and Kazuhiro Ito1

1 Section of Airway Disease, National Heart and Lung Institute, Imperial College, London, United Kingdom; and 2 University of British Columbia and the James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, St. Paul's Hospital, Vancouver, British Columbia, Canada

Correspondence and requests for reprints should be addressed to Kazuhiro Ito, Ph.D., Section of Airway Disease, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. E-mail: k.ito{at}imperial.ac.uk

Rationale: Nitric oxide (NO) is increased in the lung periphery of patients with chronic obstructive pulmonary disease (COPD). However, expression of the NO synthase(s) responsible for elevated NO has not been identified in the peripheral lung tissue of patients with COPD of varying severity.

Objectives:

Methods: Protein and mRNA expression of nitric oxide synthase type I (neuronal NOS [nNOS]), type II (inducible NOS [iNOS]), and type III (endothelial NOS [eNOS]) were quantified by Western blotting and reverse transcription-polymerase chain reaction, respectively, in specimens of surgically resected lung tissue from nonsmoker control subjects, patients with COPD of varying severity, and smokers without COPD, and in a lung epithelial cell line (A549). The effects of nitrative/oxidative stress on NOS expression and activity were also evaluated in vitro in A549 cells. nNOS nitration was quantified by immunoprecipitation and dimerization of nNOS was detected by low-temperature SDS–PAGE/Western blot in the presence of the peroxynitrite generator, 3-morpholinosydnonimine-N-ethylcarbamide (SIN1), in vitro and in vivo.

Measurements and Main Results: Lung tissue from patients with severe and very severe COPD had graded increases in nNOS (mRNA and protein) compared with nonsmokers and normal smokers. Hydrogen peroxide (H2O2) and SIN1 as well as the cytokine mixture (IFN-{gamma}, IL-1β, and tumor necrosis factor-{alpha}) increased mRNA expression and activity of nNOS in A549 cells in a concentration-dependent manner compared with nontreated cells. Tyrosine nitration resulted in an increase in nNOS activity in vitro, but did not affect its dimerization.

Conclusions: Patients with COPD have a significant increase in nNOS expression and activity that reflects the severity of the disease and may be secondary to oxidative stress.

Key Words: nitric oxide synthase • nitrosative stress • nitration • chronic obstructive pulmonary disease


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Nitric oxide is increased in the peripheral lungs of patients with chronic obstructive pulmonary disease (COPD); however, the source is unclear.

What This Study Adds to the Field
Neuronal nitric oxide synthase expression and activity are increased in patients with COPD according to the severity of their disease, and this may be the cause of high levels of nitrative stress in peripheral lung.

 

Related articles in AJRCCM:

Nitric Oxide Synthase Isoforms in Lung Parenchyma of Patients with Chronic Obstructive Pulmonary Disease
Massimo Corradi and Antonio Mutti
AJRCCM 2010 181: 3-4. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Corradi and A. Mutti
Nitric Oxide Synthase Isoforms in Lung Parenchyma of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2010; 181(1): 3 - 4.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2010 American Thoracic Society
  Subscribe to PATS